311 related articles for article (PubMed ID: 14695992)
1. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
2. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
3. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
5. PLAG1 activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2).
Röpke A; Kalinski T; Kluba U; von Falkenhausen U; Wieacker PF; Röpke M
Cytogenet Genome Res; 2007; 119(1-2):33-8. PubMed ID: 18160779
[TBL] [Abstract][Full Text] [Related]
6. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
7. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.
Aström AK; Voz ML; Kas K; Röijer E; Wedell B; Mandahl N; Van de Ven W; Mark J; Stenman G
Cancer Res; 1999 Feb; 59(4):918-23. PubMed ID: 10029085
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
9. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
12. [Molecular techniques lead to the first insights into the pathophysiology of salivary gland adenomas].
Kas K
Verh K Acad Geneeskd Belg; 2001; 63(1):35-40. PubMed ID: 11284386
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
[TBL] [Abstract][Full Text] [Related]
16. FOXG1 is overexpressed in hepatoblastoma.
Adesina AM; Nguyen Y; Guanaratne P; Pulliam J; Lopez-Terrada D; Margolin J; Finegold M
Hum Pathol; 2007 Mar; 38(3):400-9. PubMed ID: 17217994
[TBL] [Abstract][Full Text] [Related]
17. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
[TBL] [Abstract][Full Text] [Related]
18. Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification.
Tsang YT; Chang YM; Lu X; Rao PH; Lau CC; Wong KK
Cancer Genet Cytogenet; 2004 Jul; 152(2):124-8. PubMed ID: 15262430
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays.
Suzuki M; Kato M; Yuyan C; Takita J; Sanada M; Nannya Y; Yamamoto G; Takahashi A; Ikeda H; Kuwano H; Ogawa S; Hayashi Y
Cancer Sci; 2008 Mar; 99(3):564-70. PubMed ID: 18271875
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic adenoma gene 1 is expressed in cultured benign and malignant salivary gland tumor cells.
Queimado L; Lopes C; Du F; Martins C; Bowcock AM; Soares J; Lovett M
Lab Invest; 1999 May; 79(5):583-9. PubMed ID: 10334569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
